Navigation Links
Neuro-Biotech's Solution for a Doctor near You: Early Detection for Alzheimer's and Chronic Fatigue Syndrome!

BASEL, Switzerland, Sept. 20 /PRNewswire-FirstCall/ - Neuro-Biotech Corporation (PINKSHEETS: MRES) (OTCQB: MRES) is a worldwide based biotechnological enterprise involved in the unique international niche of clinical neuroscience diagnostic testing. Neuro-Biotech's presently has the opportunity to market 12 clinical "Neuro Blood Tests" through partnerships. Neuro-Biotech's proprietary diagnostic tests are without equal in being rapidly done as an essential complement to current clinical laboratory testing procedures, by being non-invasive, sensitive, and reliable. This will provide general practitioners and specialists alike, useful medical parameters in the analysis and treatment of workplace stress-related diseases and mental-health disorders, such as Alzheimer's.

As a result of more than 20 years of research and development (R&D), Neuro-Biotech Corp.'s specific expertise is the understanding of the communication between the brain and the human body and their various influences on the peripheral systems, in order to maintain the internal equilibrium of a person's state of mind.

This exclusive understanding of the relationships between the neurotransmitter families within the brain led to the development of a portfolio of in vitro diagnostic blood tests. They will be used for the detection, prevention, monitoring and follow-up of the major psycho-social environmental diseases. They can be stress-related, socio-professional and occupational diseases, such as Chronic Fatigue Syndrome (CFS), Great Anxiety (GA), Panic Syndrome (PS); Cardiovascular diseases like Essential Hypertension or Arrhythmia; Neurodegenerative diseases such as Alzheimer or Parkinson's Disease as well as Mental-Health Disorders in the vein of Depression and Schizophrenia

Caregivers can now evaluate and establish an individual's ability to react to stress by monitoring bio-indicators within the blood or other biological fluids. Efficient and improved patient supervision, treatment and follow-up care can be instituted.

Clinical Neuroscience-related diseases can be difficult to diagnose and complex to treat. If we don't know the full state of health of an individual and the progression of the therapy... How can we truly manage the care and rehabilitation? Neuro-Biotech Corp. has the solution!

SOURCE Neuro-Biotech Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses
2. Marrone Bio Innovations to Present Invasive Mussel Control Solution
3. Applied Precision Installs New DeltaVision
4. OMX® Super-Resolution Imaging System in the Light Microscopy Imaging Center at Indiana University
5. Scientists achieve highest-resolution MRI of a magnet
6. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
7. Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView
8. BioSpec Global Solutions Inc. Enters into talks with possible Chinese partner
9. Case Western Reserve University-led team takes high resolution photo of a K+ channel
10. Promega Now Offers Complete Solution for Profiling Kinase Inhibitor Compounds Against the Human Kinome
11. Haydon Kerk Motion Solutions Introduces the RGS04 Dual Carriage Linear Rail and Programmable Actuator Assembly
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015 Cepheid (Nasdaq: CPHD ... at the Piper Jaffray Healthcare Conference in ... Company is reaffirming its outlook for the fourth quarter ... addition to discussing longer term business model expectations. ... Officer.  "We continue to be the fastest growing company ...
(Date:12/1/2015)... , December 1, 2015 ... of the  "2016 U.K. Virology and Bacteriology ... for 100 Tests, Supplier Shares by Test, ... to their offering.  --> ... "2016 U.K. Virology and Bacteriology Testing Market: ...
(Date:11/30/2015)... MIAMI (PRWEB) , ... November 30, 2015 , ... Global Stem Cells Group ... new clinics in the cities of Arica and Iquique in northern Chile. The facilities are ... clinics offer the most advanced protocols and techniques in stem cell medicine to patients from ...
(Date:11/30/2015)... ALBANY, N.Y. , Nov. 30, 2015 /PRNewswire-USNewswire/ ... led by assistant chemistry professor Jan Halámek, is ... level.   --> ...   --> ... researchers at UAlbany have discovered a straightforward concept ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):